[ 5 ] Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage[J]. J Am Soc Nephrol, 2006, 17(11): 2974-2984.
[6]
[ 6 ] Singhal MK, Bhaskaran S, Vidgen E, et al. Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it[J]. Perit Dial Int, 2001, 20(4): 429-438.
[ 9 ] Paniagua R, Amato D, Voneshi E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial[J]. J Am Soc Nephrol, 2002, 13(5): 1307-1320.
[10]
Bargman JM, Thorpe KE, Churchill DN, et al. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study[J]. J Am Soc Nephrol, 2001, 12(10): 2158-2162.
[11]
Moist LM, Port FK, Orzol SM, et al. Predictors of loss of residual renal function among new dialysis patients[J]. J Am Soc Nephrol, 2000, 11(3): 556-564.
[12]
Liao CT, Shiao CC, Huang JW, et al. Predictors of faster decline of residual renal function in Taiwanese peritoneal dialysis patients[J]. Perit Dial Int, 2008, 28(Suppl 3): S191-S195.
[13]
Kolesnyk I, Noordzij M, Dekker FW, et al. Treatment with angiotensinⅡ inhibitors and residual renal function in peritoneal dialysis patients[J]. Perit Dial Int, 2011, 31(1): 53-59.
[14]
Reyes-Marín F, Calzada C, Ballesteros A, et al. Comparative study of enalapril vs. losartan on residual renal function preservation in automated peritoneal dialysis. A randomized controlled study[J]. Rev Invest Clin, 2012, 64(4): 315-321.
[15]
Akbari A, Knoll G, Ferguson D, et al. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis: systematic review and meta-analysis of randomized controlled trials[J]. Perit Dial Int, 2009, 29(5): 554-561.
[16]
Ryckelynck JP, Goffin é, Verger C, et al. Maintaining residual renal function in patients on dialysis[J]. Nephrol Ther, 2013, 9(6): 403-407.
[17]
Liu JH, Wang SM, Chen CC, et al. Relation of ankle-brachial index to the rate of decline of residual renal function in peritoneal dialysis patients[J]. Nephrology (Carlton), 2011, 16(2): 187-193.
